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Abstract
Nuclear factor erythroid 2-related factor 2 (Nrf2) is an antioxidant-activated transcription factor 
that recently emerged as a critical regulator of cellular defense against oxidative and inflammatory 
lesions. Resveratrol (Res) is a natural phytoalexin that exhibits multiple therapeutic potentials, 
including antioxidative and anti-inflammatory effects in animals. Paraquat (PQ) is the second most 
widely used herbicide worldwide, but it selectively accumulates in human lungs to cause oxidative 
injury and fibrosis with high mortality. Here, we analyzed the molecular mechanism of the 
fibrogenic response to PQ and its inhibition by Res and Nrf2. PQ dose-dependently caused 
toxicity in normal human bronchial epithelial cells (BEAS-2B), resulting in mitochondrial 
damage, oxidative stress, and cell death. Res at 10 µM markedly inhibited PQ toxicity. PQ at 10 
µM stimulated production of inflammatory and profibrogenic factors (tumor necrosis factor α, 
interleukin 6, and transforming growth factor β1) and induced the transformation of normal human 
lung fibroblasts (WI38-VA13) to myofibroblasts; both effects were inhibited by Res. Res strongly 
activated the Nrf2 signaling pathway and induced antioxidant response elementdependent 
cytoprotective genes. On the other hand, knockout or knockdown of Nrf2 markedly increased PQ-
induced cytotoxicity, cytokine production, and myofibroblast transformation and abolished 
protection by Res. The findings demonstrate that Res attenuates PQ-induced reactive oxygen 
species production, inflammation, and fibrotic reactions by activating Nrf2 signaling. The study 
reveals a new pathway for molecular intervention against pulmonary oxidative injury and fibrosis.
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Pulmonary fibrosis is an irreversible stage of a large heterogeneous group of chronic lung 
diseases with a 5-year mortality rate larger than 50% (Husain and Kuman, 2005). Fibrosis in 
the lungs can result from genetic, infectious, autoimmune, idiopathic, and cancer pathology 
or arise from exposure to environmental and occupational agents, such as fibers and 
particles, metals, pesticides, and anticancer drugs (Bus and Gibson, 1984; Castranova and 
Vallyathan, 2000; Husain and Kuman, 2005; Rom, 2007). The underlying mechanism for 
lung fibrosis is unclear for the most part. Several cellular responses are commonly observed 
during lung fibrosis, including injury to airway and alveolar epithelia, macrophage 
activation, and transformation of fibroblasts into myofibroblasts. Myofibroblasts synthesize 
collagen 1 and α smooth muscle actin (αSMA) to promote fibrosis and scar formation 
(Fichtner-Feigl et al., 2006; Wynn, 2008; Bonner, 2010). The molecular events governing 
these fibrogenic reactions remain poorly understood. Although research trials are ongoing, 
there is no evidence that any medication can significantly help lung fibrosis at the present 
time.
Paraquat (PQ) is a highly effective, fast-acting, and nonselective herbicide widely used in 
the world. Human exposure to PQ by either respiratory or systemic route leads to the 
accumulation of PQ in the lungs, resulting in pulmonary edema, bronchial and alveolar 
destruction, and ultimately fibrosis with high mortality, which is in part caused by the lack 
of a specific antidote (Bus and Gibson, 1984). Chronic exposure to PQ is associated with 
liver damage, kidney failure, and Parkinsonian lesions in addition to fibrosis (Ossowska et 
al., 2006; Tanner et al., 2011). Upon entering cells, PQ undergoes cyclic single-electron 
reduction/oxidation through its quaternary ammonium nitrogen atoms and bipyridyl ring, 
producing reactive oxygen species (ROS) and PQ radicals. Redox cycling is believed to play 
an important role in initiating lung damage and fibrosis by PQ. How the oxidative signals 
from PQ interact with the pathways that underlie lung fibrogenic response is poorly 
understood.
Resveratrol (Res) is a phytoalexin polyphenol produced naturally by several plants when 
under attack by bacterial and fungal pathogens. Res exhibits multiple health-promoting 
properties including antioxidative, anticancer, anti-inflammatory, antiaging, blood sugar-
lowing, and beneficial cardiovascular effects (Jang et al., 1997; Duffy and Vita, 2003; 
Leonard et al., 2003; Su et al., 2006; Valenzano et al., 2006; Elmali et al., 2007). Res 
alleviated bleomycin-induced lung injury in rats that typically progresses to fibrosis 
otherwise (Sener et al., 2007). Although the mechanism of protection by Res against 
bleomycin lung toxicity remains unclear, its beneficial effects on the vascular endothelium 
and lung epithelium involved activation of the nuclear factor erythroid 2-related factor 2 
(Nrf2) pathway (Kode et al., 2008; Ungvari et al., 2010).
Nrf2 is a cap “n” collar basic leucine zipper transcription factor ubiquitously expressed in 
mammalian cells. Nrf2 controls the antioxidant response element (ARE)-mediated 
expression of cellular detoxification enzymes and antioxidant proteins in response to a wide 
range of oxidant/antioxidant/electrophilic stimuli to protect the body (Leung et al., 2003; 
Talalay et al., 2003; Kobayashi et al., 2004; Kensler et al., 2007; Ma, 2008, 2010). Nrf2 and 
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its binding protein Keap1 are redox sensors. Modification of critical cysteine residues in 
Keap1 and Nrf2 by oxidants and electrophiles leads to suppression of the ubiquitination and 
proteasomal degradation of Nrf2 (Kobayashi et al., 2004; He et al., 2006; He and Ma, 2009, 
2010; Itoh et al., 2010; Taguchi et al., 2011). Activated Nrf2 translocates into the nucleus, 
dimerizes with small Maf proteins, and binds to ARE to up-regulate the transcription of 
cytoprotective genes. Nrf2-deficient mice have a tendency to develop autoimmune lesions 
and sponge-form leukoencephanopathy (Ma et al., 2006; Hubbs et al., 2007) and have 
increased susceptibility to toxicant-induced diseases, such as benzo[α]pyrene-induced 
cancer (Ramos-Gomez et al., 2001), metal toxicity (He et al., 2007, 2008), premature 
ovarian failure by 4-vinylcyclohexene diepoxide (Hu et al., 2006), and diabetic 
cardiomyopathy induced by high glucose (He et al., 2009). It is noteworthy that Nrf2 null 
mice are vulnerable to bleomycin and hypoxia-induced airway inflammation and lung 
fibrosis (Cho et al., 2004).
The purpose of the study was 3-fold: 1) to elucidate the molecular mechanism by which PQ 
damages human lung cells and induces fibrogenic response; 2) to examine the effect of Res 
on PQ pulmonary toxicity; and 3) to analyze the role and mechanism of action of Nrf2 in 
these processes. We found that PQ induced mitochondrial damage that, together with PQ 
redox cycling, caused heightened oxidative stress, leading to lung epithelial cell death, 
production of profibrogenic cytokines and growth factors, and myofibroblast transformation. 
Res effectively prevented PQ toxicity and blocked the fibrogenic reactions. Finally, Nrf2 
was found to be critical for defense against PQ toxicity in normal cells and the protective 
effects of Res. The findings revealed a molecular pathway for intervention against PQ lung 
fibrosis and, potentially, other fibrotic diseases.
Materials and Methods
Reagents and Cell Culture
Reagents and cells were purchased from commercial vendors: PQ (N,N′-dimethyl-4,4′-
bipyridynium dichloride; Thermo Fisher Scientific, Waltham, MA); Res (3,5,4′-trihydroxy- 
trans-stilbene; Enzo Life Sciences, Inc., Farmingdale, NY); tetramethylrhodamine ethyl 
ester (TMRE) and lipopolysaccharide (LPS) (Sigma, St. Louis, MO); MitoTracker deep red 
633 (MTDR) and cell culture media (Invitrogen, Carlsbad, CA); and BEAS-2B, WI38- 
VA13, and RAW264.7 cells (American Type Culture Collection, Manassas, VA). Mouse 
embryonic fibroblast (MEF) cells were derived from Nrf2 wild-type (WT) and knockout 
(KO) mice and immortalized as described elsewhere (Bi et al., 2004; He and Ma, 2009). 
MEFs were cultured in Dulbecco’s modified Eagle’s medium with 10% FBS and 5% CO2. 
BEAS-2B cells were cultured in basal medium Eagle’s medium with additives from Lonza 
Walkersville, Inc. (Walkersville, MD). WI38-VA13 cells were cultured in α-modified 
Eagle’s medium with 10% FBS. Raw264.7 cells were grown in Dulbecco’s modified 
Eagle’s medium with 10% FBS.
Cytotoxicity Assay
The CellTiter 96 AQueous One Solution Cell Proliferation Assay kit (Promega, Madison, 
WI) was used to detect cell proliferation/cytotoxicity following the manufacturer’s 
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instructions. Cells (1 × 105) were seeded in 96-well plates overnight. Absorbance at 490 nm 
(A490nm) was recorded, and means and S.D. were calculated from three samples for each 
treatment.
ROS Detection
Cells in an eight-well chamber slide were added with 5 µM dihydroethium (DHE; 
fluorophore for ROS; Invitrogen) 30 min before the end of treatment. Cells were fixed with 
4% paraformaldehyde and mounted with a mounting solution containing DAPI that stains 
the nucleus. Images were taken by using a Zeiss LSM510 confocal microscope (Carl Zeiss 
Inc., Thornwood, NY) with a rhodamin- DAPI setting and fixed exposure time. 
Fluorescence intensity was quantified by using Optimus version 6.51 software (Media 
Cybernetics Inc., Bethesda, MD) and expressed in relative fluorescence units (RFU). Means 
and S.D. were calculated from five separate fields for each treatment.
Measurement of Mitochondrial Inner Membrane Potential
Cells cultured in an eight-well chamber slide were added with 50 nM TMRE and 1 µM 
MTDR 45 min before the end of treatment. Cells were fixed with 4% paraformaldehyde and 
mounted with a mounting solution containing DAPI for fluorescence microscopy. 
Quantification of fluorescence intensity was performed as described above for ROS 
detection. Alternatively, TMRE and MTDR fluorescence was measured by flow cytometry, 
and data were expressed in RFU.
Immunoblotting
Cells were lysed on ice with radioimmunoprecipitation assay buffer containing protease and 
phosphatase inhibitors for 30 min. Cell lysate (40 µg) was immunoblotted with anti- Nrf2 or 
actin antibodies (Santa Cruz Biotechnology, Inc., Santa Cruz, CA). Protein bands were 
visualized by using enhanced chemiluminescence detection reagents from GE Healthcare 
(Chalfont St. Giles, Buckinghamshire, UK).
Detection of Cytokine
Cells were treated as shown in figure legends, and cell culture medium was collected. TNFα 
and IL-6 cytokines were detected by flow cytometry using mouse Flex TNFα and IL-6 
beads (BD Biosciences, San Diego, CA) following the manufacturer’s instructions.
Immunofluorescent Staining
Cells in eight-well chamber slides were fixed with 4% paraformaldehyde, permeated with 
0.5% Triton X-100, and stained with anti-αSMA antibody (Sigma) overnight at 4°C, 
followed by Alexa Fluor 594-conjugated second antibody (Invitrogen) for 1 h, avoiding 
light. Fluorescence images were taken and quantified as described above for ROS detection.
Apoptosis
BEAS-2B cells cultured in 96-well plates were added with 100 µl of the Caspase 3-Glo 3/7 
reagent (Promega) and cultured at 37°C for 1h. Luminescence was measured in a plate-
reading luminometer and expressed in relative light units (RLU).
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RAW264.7 cells stably transfected with a TNFα promoter/luciferase reporter construct were 
as described previously (Ma et al., 2003). Cells were treated and lysed with a passive 
reporter lysis buffer (Promega). Cell lysate was centrifuged briefly to remove cell debris. 
Twenty microliters of supernatant was mixed with 100 µl of luciferase reagent (Promega), 
and luciferase activity was detected by using a TD 20/20 luminometer (Molecular Devices, 
Sunnyvale, CA). Luciferase activity was in RLU and normalized with protein 
concentrations.
Real-Time PCR
Cells were treated as shown in figure legends. Total RNA was isolated by using a QIAGEN 
RNA mini kit (QIAGEN, Valencia, CA). Five micrograms of total RNA was reverse-
transcribed into cDNA with reverse transcriptase III (Invitrogen). TGFβ1 mRNA was 
amplified with gene-specific primers (primer sequences available on request) by using real-
time PCR as described previously (He et al., 2009). Actin was used as an internal control.
siRNA Transfection
Cells were transfected with either the control siRNA (Santa Cruz Biotechnology, Inc) or 
Nrf2 siRNA specific for mouse Nrf2 (Invitrogen) as described previously (He et al., 2009). 
Knockdown of Nrf2 was confirmed by immunoblotting of Nrf2.
Northern Blotting
Total RNA of 3 µg each was fractionated in a 1.2% formaldehyde agarose gel, transferred to 
a supercharged nylon membrane, and blotted with the digoxigenin-labeled riboprobe 
prepared with digoxigenin-labeling reagents (Roche Applied Science, Indianapolis, IN). 
Plasmid constructs for riboprobes of Nqo1, Ho1, and actin were verified by sequencing. 
Northern signals were visualized by chemiluminescence using a digoxigenin RNA detection 
kit with CDP Star as a substrate (Roche Applied Science).
Results
Res Inhibits PQ-Induced Cell Death, ROS Production, and Mitochondrial Damage in Human 
Lung Cells
Exposure to PQ in the lungs typically causes extensive bronchial and alveolar destruction 
before fibrosis. BEAS-2B cells, a normal human bronchial epithelium cell line, were used to 
examine PQ cytotoxicity and the effect of Res. PQ at concentrations of 10−6 to 10−4 M 
induced cell toxicity dose-dependently (Fig. 1A). Toxicity was largely attributed to 
apoptosis as revealed by caspase 3/7 activation (Fig. 1A, inset). Res at 10 µM significantly 
reduced PQ toxicity at concentrations of 10−5 and 10−4 M.
PQ undergoes redox cycling producing . and other radicals to initiate cell killing in plants 
and animals. Incubation of BEAS-2B cells with PQ (20 µM, 24 h) dramatically increased 
ROS production (5-fold) detected by DHE, a fluorophore specific for . (Fig. 1B). Res 
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(Res + PQ; pretreated at 10 µM before PQ) significantly reduced the amount of PQ-induced 
ROS (~70%).
The mitochondria consume approximately 90% of the oxygen in cells for ATP synthesis and 
are a major source of ROS under both normal and pathological conditions. The observation 
that PQ substantially increased ROS production, whereas Res largely blocked PQ-induced 
ROS production suggests the involvement of mitochondria in PQ and Res effects. TMRE 
and MTDR are cationic lipophilic fluorophores that selectively accumulate in mitochondrial 
matrix in a mitochondrial inner membrane potential-dependent manner. Strong TMRE and 
MTDR florescence signals were found in the cytoplasm of control cells, indicating 
accumulation of the dyes in the mitochondrial matrix; however, the fluorescence was largely 
reduced and became diffusive upon treatment with PQ (20 µM; 24 h), indicating 
mitochondrial damage (Fig. 1, C and D). On the other hand, pretreatment with Res for 16 h 
followed by PQ restored the fluorescence intensity, indicating PQ-induced mitochondrial 
damage was largely prevented by Res.
Res Blocks PQ-Induced Fibroblast-to-Myofibroblast Transformation by Suppressing the 
Production of Inflammatory and Profibrogenic Factors
Fibrogenic agents induce the production and secretion of inflammatory and profibrogenic 
cytokines and growth factors from macrophages, epithelial cells, and fibroblasts. The 
soluble factors function as paracrines and autocrines to stimulate inflammation and fibrosis. 
To examine the effects of PQ and Res on the expression of profibrogenic factors, a 
luciferase reporter under the control of mouse TNFα promoter was examined for induction 
in RAW264.7 cells, a widely used macrophage cell line (Fig. 2A). PQ (10 µM; 16 h) 
induced reporter expression. Res itself (10 µM; 16 h) did not affect reporter expression, but 
cotreatment with Res blocked reporter induction by PQ. Res also weakly, but significantly, 
reduced reporter induction by LPS, a known inducer of TNFα. Expression of endogenous 
genes was examined. PQ (10 µM; 24 h) induced production of TNFα (Fig. 2B) and IL-6 
(Fig. 2C) proteins in macrophages and TNFβ1 mRNA in fibroblasts (Fig. 2D). Pretreatment 
with Res at 10 µM for 16 h totally blocked induction of TNFα and IL-6 proteins and 
significantly diminished the induction of TNFβ1 mRNA by PQ.
Transformation of fibroblast to myofibroblast is a critical cellular event in fibrosis because 
the latter synthesizes collagen I and αSMA, two major proteins involved in fibrosis and scar 
formation. WI38-VA13 cells, a normal human lung fibroblast cell line, were used to assess 
the effects of PQ and Res on myofibroblast transformation. PQ (10 µM; 24 h) induced a 
significant increase (>3-fold) in the amount of αSMA, indicating transformation of 
fibroblasts to myofibroblasts (Fig. 3). Res itself (10 µM) did not affect αSMA expression, 
but pretreatment with Res markedly reduced PQ-induced increase in αSMA. Thus, PQ 
stimulated myofibroblast transformation, whereas Res blocked the transformation.
Res Activates Nrf2 to Induce Cytoprotective Genes
Nrf2 controls the cellular defense against oxidative and electrophilic chemicals and lesions. 
The profound oxidative effect by PQ and its inhibition by Res in lung cells raised the 
possibility that Nrf2 is involved in the actions of PQ and Res. As shown in Fig. 4A, Res (10 
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µM; 24 h) strongly and PQ (10 µM; 24 h) weakly increased the protein level of Nrf2 in 
BEAS-2B cells, indicating activation of Nrf2. Cotreatment with Res and PQ further 
increased Nrf2 protein, suggesting a synergy between Res and PQ for Nrf2 activation. 
Northern blotting was performed to analyze the induction of Nqo1 and Ho1, two 
representative target genes of Nrf2 (Fig. 4B). tBHQ (30 µM), a known inducer of Nqo1 and 
Ho1, strongly induced the genes. Res (10 µM) induced Nqo1 similarly to tBHQ and Ho1 to a 
less extent. PQ induced both genes at 100 but not 10 µM. Therefore, Res and, to a lesser 
extent, PQ activated Nrf2 signal transduction to induce cytoprotective genes.
Nrf2 Controls Defense against the Cytotoxicity, Oxidative Stress, and Mitochondrial 
Damage of PQ and Mediates Protection by Res
The role of Nrf2 in PQ toxicity and protection by Res was examined by comparing Nrf2 WT 
and KO MEFs. PQ at 10−5 and 10−4M caused significant toxicity in WT cells, and Res at 10 
µM significantly reduced the toxicity (Fig. 5A) in agreement with the data for BEAS-2B 
cells (Fig. 1A). In KO cells, PQ induced significantly a higher level of toxicity than wild 
type and Res failed to rescue. The results indicate that Nrf2 is required for defense against 
PQ toxicity in normal cells and for protection by Res.
In WT cells, PQ (10 µM) induced a dramatic increase of ROS production. Res (10 µM) 
alone did not significantly change the ROS level, but Res cotreatment blocked PQ-induced 
ROS production (Fig. 5, B and C). In KO cells, the basal ROS production was increased 
(compare control KO with control WT); PQ induced a high level of ROS; Res alone did not 
significantly change ROS level; and Res failed to block PQ-induced ROS production. The 
data revealed that Nrf2 is critically involved in the control of ROS production in cells 
exposed to PQ and is required for the suppression of PQ-induced oxidative stress by Res.
The effect of Nrf2 on PQ toxicity to BEAS-2B mitochondria was examined by using siRNA 
knockdown of Nrf2 (Fig. 5, D and E). Knockdown of Nrf2 significantly reduced the protein 
level of Nrf2 (Fig. 5D). Knockdown of Nrf2 or treatment with Res (10 µM) alone did not 
alter the mitochondrial inner membrane integrity, but PQ (10 µM) significantly reduced 
TMRE accumulation in mitochondrial matrix in both control and Nrf2 knockdown cells 
(Fig. 5E). Cotreatment with Res rescued the cells from PQ-induced mitochondrial damage in 
WT but not Nrf2 knockdown cells, indicating Nrf2 is required for Res protection against PQ 
toxicity to mitochondria.
Nrf2 Inhibits Induction of Profibrogenic Factors and Transformation of Myofibroblast by 
PQ
The effect of Nrf2 on the regulation of inflammatory and profibrogenic cytokine and growth 
factor expression by PQ and Res was examined in macrophages transfected with control or 
Nrf2 siRNA (Fig. 6). Nrf2 protein was significantly diminished in macrophages upon 
knockdown of Nrf2 (Fig. 6A). PQ (10 µM; 24 h) induced TNFα secretion from 
macrophages, and induction was significantly higher in Nrf2 knockdown cells, suggesting 
Nrf2 suppresses TNFα expression in macrophages (Fig. 6B). Res (pretreated for 16 h at 10 
µM) blocked TNFα induction by PQ in control but not Nrf2 knockdown cells. Similar 
effects of Nrf2 knockdown were observed for the induction of IL-6 protein (Fig. 6C) and 
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TNFβ1 mRNA (Fig. 6D) by PQ and inhibition by Res. Thus, Nrf2 inhibited PQ induction of 
the cytokines and growth factors in WT cells, and Nrf2 is required for Res to block 
induction by PQ.
PQ (10 µM; 24 h) induced transformation of Nrf2 WT fibroblasts into myofibrobasts as 
evidenced by marked increase in the synthesis of αSMA (Fig. 7). Res (10 µM) alone did not 
affect αSMA expression, but pretreatment with Res at 10 µM for 16 h markedly inhibited 
induction of αSMA by PQ. In Nrf2 KO fibroblasts, PQ induced significantly higher amounts 
of αSMA than in WT cells, and this increase was not affected by Res pretreatment. 
Therefore, Nrf2 inhibited PQ-induced myofibroblast transformation, and Nrf2 was required 
for suppression of PQ-induced fibrotic reaction by Res.
Discussion
The hallmark of PQ pulmonary toxicity is extensive tissue damage followed by fibrosis after 
either respiratory or systemic exposure (Bus and Gibson, 1984), which resembles the 
toxicity of a number of pulmonary toxicants, such as bleomycin and nitrofurantoin. In the 
case of PQ, the quaternary ammonium bipyridyl structure makes it prone to cyclic one-
electron reduction/oxidation that causes production of ROS and depletion of reducing 
equivalents NADPH and GSH, both contributing to oxidative stress in cells. Thus, PQ 
serves as a valuable model compound for studying pulmonary toxicity and fibrosis, in 
particular, oxidative stress in lung fibrosis.
In this study, we analyzed the mechanism of the fibrogenic response to PQ and its inhibition 
by Res and Nrf2 in lung cells. Taken together, the findings illustrate a molecular model in 
which PQ induces oxidative stress and fibrotic reactions in lung cells, whereas Res 
suppresses PQ-induced oxidative stress and fibrogenic responses by activating the Nrf2 
pathway (Fig. 8). PQ induces oxidative stress through both redox cycling and mitochondrial 
damage. Oxidative stress stimulates fibrogenic responses by promoting production and 
secretion of inflammatory and profibrogenic factors from macrophages and other lung cells, 
transformation of fibroblasts to myofibroblasts, and synthesis of αSMA and collagen 1. Res 
activates Nrf2 and induces cytoprotective genes to inhibit PQ-induced ROS production, 
mitochondrial damage, cytokine and growth factor expression, and myofibroblast 
transformation.
The mitochondria are a major organelle for oxygen consumption and ROS production in 
cells. We found that mitochondria are a major target of PQ and damage to mitochondria 
contributes to oxidative stress induced by PQ. In this regard, PQ-induced mitochondrial 
damage and PQ redox cycling form a vicious cycle to cause heightened oxidative stress in 
lung cells. The observations that loss of Nrf2 in cells exacerbated PQ-induced ROS 
production and mitochondrial toxicity, whereas antioxidant Res blocked PQ oxidative stress 
and toxicity, support the notion that oxidative stress and mitochondrial damage are major 
mechanisms by which PQ causes lung damage and fibrosis.
Res is one of the promising natural products with multiple health-promoting effects (Vang et 
al., 2011). In this study, Res was shown, for the first time, to inhibit PQ-induced oxidative 
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damage, expression of profibrogenic cytokines and growth factors, and transformation of 
fibroblasts into myofibroblasts effectively. Several lines of evidence support that Nrf2 
mediates the protective effect of Res against PQ lung toxicity and fibrosis. First, Res 
elevated the Nrf2 protein level and induced Nrf2/ARE-controlled cytoprotective genes Nqo1 
and Ho1 in lung cells. Second, PQ induced oxidative stress and fibrogenic reactions that 
were more severe in Nrf2 KO than WT cells. Third, Res could reverse or attenuate PQ-
induced ROS production and fibrogenic responses in WT but not KO cells. Finally, a body 
of literature exists indicating a critical role of Nrf2 in Res functions. For instance, activation 
of Nrf2 is an important mechanism by which Res exerts its protective effects in the vascular 
endothelium (Ungvari et al., 2010). Res protects against cigarette smokemediated oxidative 
damage by activating Nrf2 in human lung epithelial cells (Kode et al., 2008), and both Nrf2 
and Res protect against bleomycin-induced lung damage and fibrosis (Cho et al., 2004; 
Sener et al., 2007).
Cytokines and growth factors are involved in both the early inflammatory and late fibrotic 
phases of lung fibrosis through paracrine and autocrine mechanisms. TNFα is one of the 
early cytokines consistently found in animal models of pulmonary fibrosis and plays a 
cardinal role in the pathogenesis of this disease. TNFα activates nuclear factor-κB and 
activator protein 1 that regulate the proliferation of fibroblasts and expression of cellular 
matrix deposition genes, such as matrix metalloproteinase-9. IL-6 promotes fibrogenesis 
either alone or in concert with TNFα. IL-6 mRNA level is elevated in idiopathic pulmonary 
fibrosis (Smith et al., 1998). Overexpression of IL-6 in the lungs does not seem to be 
sufficient to induce marked fibrosis, but an abnormal IL-6 level has been consistently 
detected in animal and human lung fibrosis samples (Baecher-Allan and Barth, 1993; 
Moodley et al., 2003). We found that PQ significantly increased the expression of TNFα and 
IL-6 in macrophages, but pretreatment with Res prevented induction of TNFα and IL-6 by 
PQ.
TNFβ1 is a critical regulator of cell growth and differentiation as well as matrix protein 
production. Elevated production of TNFβ1 has been associated with human and rodent 
chronic inflammatory and fibrotic diseases. For instance, bleomycin-induced pulmonary 
fibrosis is accompanied by enhanced expression of TNFβ1, collagen 1, and αSMA (Zhang et 
al., 1996). TNFβ induces the proliferation and differentiation of ex vivo human lung 
fibroblasts into myofibroblasts through extracellular signal-regulated kinase/Akt inhibition 
and Pten restoration, whereas Res inhibits this process (Fagone et al., 2011). PQ increased 
TNFβ1 production, but pretreatment with Res for 16 h could prevent PQ-induced TNFβ1 
expression.
The primary effecter cells in fibrosis are myofibroblasts, which are highly synthetic for 
collagen 1, have a contractile phenotype, and are characterized by de novo synthesis of 
αSMA stress fiber. Myofibroblasts may derive from activation/proliferation of resident lung 
fibroblasts, through epithelial-mesenchymal differentiation, or via recruitment of circulating 
fibroblastic stem cells. Resting fibroblasts express only β- and γ-actin isoforms (Herman, 
1993; Khaitlina, 2001), whereas activated fibroblasts synthesize αSMA. Res could inhibit 
αSMA expression in hepatic stellate cells (Kawada et al., 1998). Olson et al. (2005) 
demonstrated an inhibitory role of Res in cardiac fibroblast proliferation and myofibroblast 
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formation by reducing αSMA expression and stress fiber organization in cardiac fibroblasts. 
Res also alleviates bleomycin- induced pulmonary fibrosis (Sener et al., 2007). We found 
that PQ treatment for 24 h elevated αSMA expression in lung fibroblast WI38VA13 cells, 
but pretreatment with Res for 16 h inhibited PQ-induced αSMA expression, providing the 
first evidence that Res could effectively prevent PQinduced fibrogenic response in lung 
cells. These data provide a rationale for exploring the therapeutic and chemoprotective 
potentials of Res for the treatment and prevention of pathologic conditions involving 
pulmonary fibrosis.
ABBREVIATIONS
αSMA αsmooth muscle actin
ARE antioxidant response element
DAPI 4,6-diamidino-2-phenylindole
DHE dihydroethium
FBS fetal bovine serum




MEF mouse embryonic fibroblast
MTDR MitoTracker deep red 633
Nqo1 NAD(P)H:quinone oxidoreductase
Nrf2 nuclear factor erythroid 2-related factor 2
PCR polymerase chain reaction
PQ paraquat
Res resveratrol
RFU relative fluorescence unit
RLU relative light unit
ROS reactive oxygen species
siRNA small interfering RNA
tBHQ tert-butylhydroquinone
TGF transforming growth factor
TMRE tetramethylrhodamine ethyl ester
TNF tumor necrosis factor
WT wild type
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Inhibition of PQ toxicity by Res. A, cytotoxicity. BEAS-2B cells were treated with PQ or 
PQ + Res (10 µM) for 24 h in triplicate. Cytotoxicity was detected by using CellTiter 96 
AQueuos One Solution Reagent. Data represent means from three samples. Inset, apoptosis 
(caspase 3/7 activation) was measured in cells treated with PQ at 10 µM for 24 h. Caspase 
activity was expressed in RLU. B, ROS production. Cells were treated with Res (10 µM) for 
16 h then with or without PQ (20 µM) for 24 h. ROS production was measured by using 
fluorophore DHE and expressed in RFU. Data represent means ± S.D. from three samples. 
C, mitochondrial damage. Cells were treated as in B. Mitochondrial damage was assayed by 
using fluorophores TMRE (green) and MTDR (red). DAPI (blue) was used to counterstain 
the nucleus. Composite images show the mitochondria in yellow (merge of green and red). 
Bar size, 20 nm. D, quantification of TMRE and MTDR fluorescence.*, p < 0.05; **, p < 
0.01.
He et al. Page 14














Suppression of PQ-induced expression of TNFα, IL-6, and TNFβ1 by Res. A, TNFα 
promoter/luciferase reporter expression. Macrophages stably transfected with the TNFα 
promoter-luciferase reporter plasmid were treated with LPS (1 µg/ml; positive control), PQ 
(10 µM), Res (10 µM), LPS + Res, or PQ + Res for 16 h. Luciferase reporter expression was 
measured and expressed in RLU. B and C, secretion of TNFα (B) and IL-6 (C). 
Macrophages were pretreated with Res (10 µM) for 16 h followed by PQ (10 µM) for 
another 24 h (Res + PQ). LPS (1 µg/ml, 5 h) was a positive control for induction. The 
culture medium was assayed for TNFα (B) or IL-6 (C) proteins by flow cytometry using 
TNFα and IL-6 Flex beads. D, expression of TNFβ1 mRNA. WI38-VA13 cells were treated 
with PQ (10 µM) for 24 h or Res (10 µM) for 16 h followed by PQ for another 24 h (Res + 
PQ). Total RNA was assayed for TNFβ1 mRNA expression by using real-time PCR. Actin 
was used as a loading control. Data represent means ± S.D. from three samples.*, p < 0.05; 
**, p < 0.01; ***, p < 0.001.
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Inhibition of PQ-induced myofibroblast transformation by Res. WI38-VA13 cells were 
treated with PQ (10 µM), Res (10 µM), or PQ + Res (pretreated for 16 h) for 24 h. 
Immunostaining was performed with an anti-αSMA antibody followed by Alex 549-
conjugated second antibody (red). A, images were taking by confocal microscopy. The 
nucleus was counterstained with DAPI (blue). Bars, 20 nm. B, quantification of the images 
taken from five representative separate fields. **, p < 0.01; ***, p < 0.001.
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Activation of Nrf2. A, Nrf2 protein stabilization. BEAS-2B cells were treated with Res (10 
µM), PQ (10 µM), or PQ + Res for 24 h. Total cell lysates were immunoblotted with an anti-
Nrf2 antibody. Actin was used as loading control. B, induction of Nqo1 and Ho1 mRNA. 
BEAS-2B cells were treated with tBHQ (30 µM), Res (10 µM), PQ (10 and 100 µM), Res + 
PQ (10 µM), or Res + PQ (100 µM) for 24 h. Total RNA was fractionated on 1.2% 
formaldehyde agarose gel. RNA bands were blotted with digoxigenin-labeled probes for 
Nqo1, Ho1, and actin and visualized with the CDP Star reagents and chemiluminescence.
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Nrf2-dependent inhibition of PQ toxicity. A, cell toxicity. Nrf2 WT and Nrf2 KO MEF cells 
were treated with PQ or PQ + Res (10 µM) for 24 h in triplicate. Cytotoxicity was measured 
and analyzed as described for Fig. 1. B, ROS production. Nrf2 WT and Nrf2 KO MEF cells 
were treated with PQ (10 µM), Res (10 µM), or PQ + Res for 24 h. ROS fluorescent probe 
DHE was added 30 min before the end of treatment to detect ROS. DAPI was used to 
counterstain the nucleus. Bars, 20 nm. C, quantification of fluorescence intensity of B. D 
and E, BEAS-2B cells were transfected with control siRNA or Nrf2 siRNA. The cells were 
then treated as described for B. D, knockdown of Nrf2 was examined by immunoblotting of 
Nrf2 with actin as the loading control. E, mitochondrial damage was assessed by using 
TMRE and flow cytometry. Data represent means ± S.D. from three samples. *, p < 0.05; 
**, p < 0.01.
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Effect of Nrf2 on cytokine expression. RAW264.7 macrophages were transfected with 
control siRNA or Nrf2 siRNA and then treated with PQ (10 µM) or Res + PQ (pretreated 
with Res at 10 µM for 16 h followed by PQ for 24 h). A, knockdown of Nrf2 is shown by 
immunoblotting. B and C, TNFα (B) and IL-6 (C) proteins in the culture medium were 
detected by flow cytometry. D, induction of TNFβ1 mRNA was examined by real-time 
PCR. *, p < 0.05;**, p < 0.01; ***, p < 0.001.
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Nrf2-dependent suppression of myofibroblast transformation. A, Nrf2 WT and Nrf2 KO 
MEF cells were treated with PQ (10 µM), Res (10 µM), or Res + PQ (pretreated with Res at 
10 µM for 16 h followed by PQ for 24 h). Fibroblast-to-myofibroblast transformation was 
assayed by immunostaining αSMA protein. Bars, 20 nm. B, quantification of fluorescence 
from five separate fields.*, p < 0.05; **, p < 0.01.
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A working model for PQ-induced lung fibrosis and protection by Res through Nrf2. Within 
lung cells, PQ undergoes one-electron redox cycling, leading to the production of PQ 
radicals and ROS ( , H2O2, and -OH), and depletion of reducing equivalents (NADPH, 
GSH), both damaging the mitochondria and further increasing ROS production to result in a 
vicious cycle of oxidative stress. Oxidative stress and epithelial damage stimulate 
macrophages as well as epithelial and fibroblast cells to produce inflammatory and 
profibrogenic cytokines and growth factors to induce myofibroblast transformation and, 
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ultimately, fibrosis. Res inhibits both the oxidative damage and fibrogenic reactions by PQ. 
Nrf2 is required for both defense against PQ oxidative and fibrogenic toxicity in normal 
cells and protection by Res against PQ through upregulating cytoprotective gene expression.
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